Montai Therapeutics is leveraging NVIDIA's BioNeMo DiffDock NIM to develop an advanced multimodal #AI #drugdiscovery platform, incorporating a library of Anthromolecule chemistry. This approach has led to the creation of a highly accurate and efficient model, capable of generating 40 poses per ligand using 8xA100 GPUs, with a processing speed of 0.76 seconds per ligand. Read more on our latest technical blog. #healthcare
Serge Palaric’s Post
More Relevant Posts
-
Montai Therapeutics is leveraging NVIDIA's BioNeMo DiffDock NIM to develop an advanced multimodal #AI #drugdiscovery platform, incorporating a library of Anthromolecule chemistry. This approach has led to the creation of a highly accurate and efficient model, capable of generating 40 poses per ligand using 8xA100 GPUs, with a processing speed of 0.76 seconds per ligand. Read more on our latest technical blog. #healthcare
Spotlight: Montai Builds a Multimodal AI Platform for Drug Discovery Using NVIDIA NIM Microservices | NVIDIA Technical Blog
developer.nvidia.com
To view or add a comment, sign in
-
Montai Therapeutics is leveraging NVIDIA's BioNeMo DiffDock NIM to develop an advanced multimodal #AI #drugdiscovery platform, incorporating a library of Anthromolecule chemistry. This approach has led to the creation of a highly accurate and efficient model, capable of generating 40 poses per ligand using 8xA100 GPUs, with a processing speed of 0.76 seconds per ligand. Read more on our latest technical blog. #healthcare
Spotlight: Montai Builds a Multimodal AI Platform for Drug Discovery Using NVIDIA NIM Microservices | NVIDIA Technical Blog
developer.nvidia.com
To view or add a comment, sign in
-
Montai Therapeutics is leveraging NVIDIA's BioNeMo DiffDock NIM to develop an advanced multimodal #AI #drugdiscovery platform, incorporating a library of Anthromolecule chemistry. This approach has led to the creation of a highly accurate and efficient model, capable of generating 40 poses per ligand using 8xA100 GPUs, with a processing speed of 0.76 seconds per ligand. Read more on our latest technical blog. #healthcare
Spotlight: Montai Builds a Multimodal AI Platform for Drug Discovery Using NVIDIA NIM Microservices | NVIDIA Technical Blog
developer.nvidia.com
To view or add a comment, sign in
-
Montai Therapeutics is leveraging NVIDIA's BioNeMo DiffDock NIM to develop an advanced multimodal #AI #drugdiscovery platform, incorporating a library of Anthromolecule chemistry. This approach has led to the creation of a highly accurate and efficient model, capable of generating 40 poses per ligand using 8xA100 GPUs, with a processing speed of 0.76 seconds per ligand. Read more on our latest technical blog. #healthcare
Spotlight: Montai Builds a Multimodal AI Platform for Drug Discovery Using NVIDIA NIM Microservices | NVIDIA Technical Blog
developer.nvidia.com
To view or add a comment, sign in
-
Montai Therapeutics is leveraging NVIDIA's BioNeMo DiffDock NIM to develop an advanced multimodal #AI #drugdiscovery platform, incorporating a library of Anthromolecule chemistry. This approach has led to the creation of a highly accurate and efficient model, capable of generating 40 poses per ligand using 8xA100 GPUs, with a processing speed of 0.76 seconds per ligand. Read more on our latest technical blog. #healthcare
Spotlight: Montai Builds a Multimodal AI Platform for Drug Discovery Using NVIDIA NIM Microservices | NVIDIA Technical Blog
developer.nvidia.com
To view or add a comment, sign in
-
Montai Therapeutics is leveraging NVIDIA's BioNeMo DiffDock NIM to develop an advanced multimodal #AI #drugdiscovery platform, incorporating a library of Anthromolecule chemistry. This approach has led to the creation of a highly accurate and efficient model, capable of generating 40 poses per ligand using 8xA100 GPUs, with a processing speed of 0.76 seconds per ligand. Read more on our latest technical blog. #healthcare
Spotlight: Montai Builds a Multimodal AI Platform for Drug Discovery Using NVIDIA NIM Microservices | NVIDIA Technical Blog
developer.nvidia.com
To view or add a comment, sign in
-
Montai Therapeutics is leveraging NVIDIA's BioNeMo DiffDock NIM to develop an advanced multimodal #AI #drugdiscovery platform, incorporating a library of Anthromolecule chemistry. This approach has led to the creation of a highly accurate and efficient model, capable of generating 40 poses per ligand using 8xA100 GPUs, with a processing speed of 0.76 seconds per ligand. Read more on our latest technical blog. #healthcare
Spotlight: Montai Builds a Multimodal AI Platform for Drug Discovery Using NVIDIA NIM Microservices | NVIDIA Technical Blog
developer.nvidia.com
To view or add a comment, sign in
-
Montai Therapeutics is leveraging NVIDIA's BioNeMo DiffDock NIM to develop an advanced multimodal #AI #drugdiscovery platform, incorporating a library of Anthromolecule chemistry. This approach has led to the creation of a highly accurate and efficient model, capable of generating 40 poses per ligand using 8xA100 GPUs, with a processing speed of 0.76 seconds per ligand. Read more on our latest technical blog. #healthcare
Spotlight: Montai Builds a Multimodal AI Platform for Drug Discovery Using NVIDIA NIM Microservices | NVIDIA Technical Blog
developer.nvidia.com
To view or add a comment, sign in
-
Montai Therapeutics is leveraging NVIDIA's BioNeMo DiffDock NIM to develop an advanced multimodal #AI #drugdiscovery platform, incorporating a library of Anthromolecule chemistry. This approach has led to the creation of a highly accurate and efficient model, capable of generating 40 poses per ligand using 8xA100 GPUs, with a processing speed of 0.76 seconds per ligand. Read more on our latest technical blog. #healthcare
Spotlight: Montai Builds a Multimodal AI Platform for Drug Discovery Using NVIDIA NIM Microservices | NVIDIA Technical Blog
developer.nvidia.com
To view or add a comment, sign in
-
Montai Therapeutics is leveraging NVIDIA's BioNeMo DiffDock NIM to develop an advanced multimodal #AI #drugdiscovery platform, incorporating a library of Anthromolecule chemistry. This approach has led to the creation of a highly accurate and efficient model, capable of generating 40 poses per ligand using 8xA100 GPUs, with a processing speed of 0.76 seconds per ligand. Read more on our latest technical blog. #healthcare
Spotlight: Montai Builds a Multimodal AI Platform for Drug Discovery Using NVIDIA NIM Microservices | NVIDIA Technical Blog
developer.nvidia.com
To view or add a comment, sign in